Overview

A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants

Status:
COMPLETED
Trial end date:
2025-02-24
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the effect of multiple-dose administration of carbamazepine on the pharmacokinetics of S-892216 in healthy adults.
Phase:
PHASE1
Details
Lead Sponsor:
Shionogi
Treatments:
Carbamazepine